Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| UniQure N.V., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| UniQure N.V., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| UniQure N.V., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| UniQure N.V., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 9 | 1 |
| UniQure N.V., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 10 | 2 |
| UniQure N.V., Pharmaceuticals &Healthcare, Deal Details | 12 | 29 |
| Venture Financing | 12 | 1 |
| uniQure Raises Additional USD10 Million in Venture Debt Financing | 12 | 1 |
| uniQure Raises US$10 Million In Venture Financing | 13 | 1 |
| UniQure Raises USD17.5 Million in Venture Financing | 14 | 2 |
| Partnerships | 16 | 1 |
| Bristol-Myers Squibb Enters into Agreement with uniQure | 16 | 2 |
| Synpromics Expands Co-Development Agreement with uniQure for Gene Therapy Vector | 18 | 1 |
| uniQure Enters Into Co-Marketing Agreement With Chiesi Farmaceutici | 19 | 2 |
| uniQure Enters Into Agreement With University of California, San Francisco To Develop Gene Therapy For Parkinson Disease | 21 | 2 |
| Amsterdam Molecular Therapeutics Enters Into An Agreement With Institut Pasteur And The Consortium | 23 | 1 |
| Licensing Agreements | 24 | 1 |
| uniQure Enters into Licensing Agreement with 4D Molecular Therapeutics | 24 | 1 |
| uniQure Enters into Licensing Agreement with Protein Sciences | 25 | 1 |
| Treeway Enters into Licensing Agreement with uniQure | 26 | 1 |
| uniQure Enters Into Licensing Agreement With Benitec Biopharma For RNA Interference Technology | 27 | 1 |
| Benitec Biopharma Enters Into Licenising Agreement With uniQure | 28 | 1 |
| uniQure Enters Into Licensing Agreement With Protein Sciences For expresSF+ Insect Cell Technology | 29 | 1 |
| Amsterdam Molecular Expands Licensing Agreement With National Institutes Of Health | 30 | 1 |
| Amsterdam Molecular Enters Into Licensing Agreement With National Institutes Of Health | 31 | 1 |
| Equity Offering | 32 | 1 |
| uniQure Raises USD38 Million in Private Placement of Shares | 32 | 1 |
| uniQure Raises USD88.5 Million in Public Offering of Shares | 33 | 2 |
| uniQure Completes IPO For US$91.8 Million | 35 | 2 |
| uniQure Announces Private Placement Of Shares For US$7.8 Million | 37 | 1 |
| Acquisition | 38 | 1 |
| UniQure Acquires InoCard for USD4 Million | 38 | 1 |
| uniQure Acquires Amsterdam Molecular Therapeutics, Developer Of Gene Therapy | 39 | 2 |
| UniQure N.V. - Key Competitors | 41 | 1 |
| Key Employees | 42 | 1 |
| Locations And Subsidiaries | 43 | 1 |
| Head Office | 43 | 1 |
| Other Locations &Subsidiaries | 43 | 1 |
| Appendix | 44 | 1 |
| Methodology | 44 | 1 |
| About GlobalData | 44 | 1 |
| Contact Us | 44 | 1 |
| Disclaimer | 44 | 1 |